Cargando…
Intratumor Heterogeneity and Therapy Resistance: Contributions of Dormancy, Apoptosis Reversal (Anastasis) and Cell Fusion to Disease Recurrence
A major challenge in treating cancer is posed by intratumor heterogeneity, with different sub-populations of cancer cells within the same tumor exhibiting therapy resistance through different biological processes. These include therapy-induced dormancy (durable proliferation arrest through, e.g., po...
Autores principales: | Mirzayans, Razmik, Murray, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073004/ https://www.ncbi.nlm.nih.gov/pubmed/32075223 http://dx.doi.org/10.3390/ijms21041308 |
Ejemplares similares
-
Intratumor Heterogeneity and Treatment Resistance of Solid Tumors with a Focus on Polyploid/Senescent Giant Cancer Cells (PGCCs)
por: Mirzayans, Razmik, et al.
Publicado: (2023) -
Molecular signature of anastasis for reversal of apoptosis
por: Tang, Ho Man, et al.
Publicado: (2017) -
Do TUNEL and Other Apoptosis Assays Detect Cell Death in Preclinical Studies?
por: Mirzayans, Razmik, et al.
Publicado: (2020) -
Transcriptomic study of anastasis for reversal of ethanol-induced apoptosis in mouse primary liver cells
por: Tang, Ho Man, et al.
Publicado: (2022) -
What Are the Reasons for Continuing Failures in Cancer Therapy? Are Misleading/Inappropriate Preclinical Assays to Be Blamed? Might Some Modern Therapies Cause More Harm than Benefit?
por: Mirzayans, Razmik, et al.
Publicado: (2022)